Concepedia

Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non–small-cell carcinoma of the lung

Roger W. Byhardt, Charles Scott, William T. Sause, Bahman Emami, Ritsuko Komaki, B. Fisher, J. S. Lee, C.A. Lawton

International Journal of Radiation Oncology*Biology*Physics · 1998 · 225 citations · 18 references

Concepts

MedicineOncologyRadiation OncologyChemotherapyClinical Radiation OncologyMedical OncologyCombination ChemotherapyConcurrent ChemoradiationLung CancerPalliative RadiotherapyRadiation TherapyRadiobiological ConsiderationsConcurrent Chemoradiotherapy ToxicityNon-small Cell Lung Cancer Adjuvant TherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentOncologic Outcomes AssessmentPatterns Of Failure

References

18

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

C. Schaake-Koning, Walter Van den Bogaert, Otilia Dalesio et al. · New England Journal of Medicine · 1992 · 1.3K citations

Medicine, Oncology, Radiation Oncology +12

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

Robert O. Dillman, Stephen L. Seagren, Kathleen J. Propert et al. · New England Journal of Medicine · 1990 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +12

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

W. T. Sause, Charles Scott, S. Taylor et al. · JNCI Journal of the National Cancer Institute · 1995 · 716 citations

Medicine, Oncology, Radiation Oncology +10

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

Carlos A. Perez, Thomas F. Pajak, Philip Rubin et al. · Cancer · 1987 · 605 citations · Full text

Medicine, Oncology, Radiation Oncology +13

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

James D. Cox, N. Azarnia, Roger W. Byhardt et al. · Journal of Clinical Oncology · 1990 · 472 citations

Medicine, Oncology, Radiation Oncology +14